Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.46 | €116.81 | 19.852% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.26 | €174.43 | 16.866% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €4.12 | €34.41 | 735.257% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.18 | €10.00 | 22.324% |
| Addus Homecare Corp. | 15 | 1 | 4 | 1 | €98.00 | €103.07 | 5.174% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €134.82 | €134.50 | -0.236% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.19 | €3.60 | 201.685% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.44 | €38.19 | 96.469% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.67 | - | - |
| Align Technology | 15 | 2 | 4 | 0 | €262.10 | €345.95 | 31.992% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.20 | €236.30 | 67.350% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €86.00 | €92.26 | 7.279% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €291.00 | €297.31 | 2.169% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.10 | €10.00 | 63.934% |
| Amn Healthcare Svs | 1 | 0 | 1 | 0 | €55.50 | - | - |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €24.00 | €46.24 | 92.667% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €39.21 | €70.00 | 78.549% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €7.21 | €11.00 | 52.566% |
| Atossa Genetics Inc | 5 | 1 | 1 | 0 | €1.58 | €3.72 | 135.044% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.57 | €10.00 | 536.943% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |